Ajovy Financial Assistance Guide

In 2018, a new class of medications was approved by the FDA for the prevention of migraine in adults. These drugs are referred to as calcitonin gene-related peptide (CGRP) inhibitors. There are currently multiple CGRP medications on the market. Dosing, frequency of use and method of action vary.
The financial assistance guide below is for anyone who has been prescribed Ajovy by their healthcare provider. Ajovy is one of three new CGRP inhibitors approved for the prevention of migraine in adults. If you or someone you know requires help with paying for treatment, review the details provided below to see if you qualify for the manufacturer’s financial assistance programs.

Most insurance companies have added at least one or two of these CGRP inhibitors to the list of medicines they cover; however, patients still struggle to receive insurance approval for the prescribed CGRP inhibitor. Each pharmaceutical company is offering financial assistance programs to help cover and/or to help cover the cost of high copays. Each program is different and various programs exist to support patients with private, government-funded insurance, as well as the uninsured.

To help patients understand each program, CHAMP created Financial Assistance Guides for the three CGRP inhibitors. These guides are not produced or approved by the medication manufacturers. CHAMP is not endorsing the use of any CGRP inhibitor over another, nor promoting the use of this new class of preventive medications for everyone with migraine disease. Every patient needs to consult their healthcare provider to determine if CGRP inhibitors are right for you.

I Have Been Prescribed Ajovy. What Financial Assistance Programs Exists To Help Me?

Find your insurance coverage and see what Financial Assistance Programs exist to help.

I Have a Private/Commercial Insurance Plan
This category includes insurance plans provided through an employer, purchased with subsidy support from the Affordable Care Act (Obamacare) or purchased privately.

Highlights of Teva Savings Card

If you have commercial drug insurance and it covers Ajovy, you may pay as little as $5. The program extends through December 2020. The Savings Card is subject to a maximum annual limit of $3500. If the maximum annual cap is reached, you may be required to pay out of pocket depending on your health plan and copay model.

This program is managed by ConnectiveRx on behalf of Teva. Teva reserves the right to make eligibility determinations, to set offer benefit maximums, to monitor participation, and to change, rescind, revoke or discontinue this offer at any time without notice.


Steps To Get Your Savings Card

  1. Your doctor writes you a prescription for Ajovy.
  2. Download or activate your Savings Offer at Ajovy.com/savings.
  3. Take your prescription Savings Offer card and primary insurance card to your regular retail pharmacy to be filled. It is important to give your Savings Offer to the pharmacist when you pick up your Ajovy prescription to ensure that you receive the offered savings.
  4. You receive your Ajovy from your pharmacy.
  5. In order to receive the Savings Offer, your commercial drug insurance must cover Ajovy. You may need to submit a prior authorization form in order to continue eligibility.

Congratulations on accessing your first dose of Ajovy! Teva will now be working behind the scenes to get your doctor to complete a prior authorization form and to get your insurance company to cover your Ajovy prescription. Contact your doctor’s office to see if they have completed the Ajovy prior authorization form on your behalf. Contact your insurance company to see if they will cover your prescribed medicine. If you have questions or encounter problems, contact Teva Shared Solutions at 1-800-887-8100

I Have Medicare, Medicaid or other Government Insurance Plan

The Teva Savings Offer is not available to patients whose medical insurance is provided by state or federal programs like Medicare, Medicaid or Tricare. This restriction is true for all three CGRP inhibitor medications.

The Federal Government does not allow people who are receiving insurance benefits through Medicare, Medicaid, etc. to use co-pay assistance, discount or savings cards offered by pharmaceutical companies. The intent is to steer patients to lower-cost generic drugs and not to support higher-cost brand-name drugs. Unfortunately, there are no generic/biosimilar medications in the class of CGRP inhibitors and won’t be for years to come.

If you are struggling to get Medicare or Medicaid to cover your prescription, speak to a Teva Shared Solutions® representative at 1-800-887-8100 who will help determine eligibility for available financial assistance programs. The call center is open Monday-Friday, 9 a.m. – 9 p.m. ET.

I Am Uninsured

The Teva Savings Offer is not available to patients who are uninsured.

The TevaCares Foundation Patient Assistance Program offers financial assistance to uninsured and underinsured patients with lower incomes. Income eligibility can cover households earning up to 500% of the Federal Poverty Level (about $60,000 for singles or up to $125,000 for a family of four). Speak to a Shared Solutions representative at 1-800-887-8100 to determine if you are eligible. The call center is open Monday-Friday, 9 a.m. – 9 p.m. ET.


Where do I turn if I am not eligible for a financial assistance program?

The Patient Advocate Foundation (a CHAMP participant organization) can be a helpful resource for patients and caregivers who are experiencing access challenges. PAF provides a suite of expert tips to help navigate insurance denials, appeals and common barriers at: patientadvocate.org/migrainematters.

PAF also offers one-on-one case management assistance through its dedicated Migraine Careline for people living with migraine who experience access challenges. The Migraine Careline provides assistance with: navigating eligibility and enrollment in disability benefits; overcoming insurance coverage; and financial burdens that impact patient access to care.

All services are completely free and provided through phone and/or email communication. Visit migraine.pafcareline.org or call 866-688-3625 to speak with a case manager today.

Ajovy Basics

  • Brand Name


  • Biologic Name

  • fremanezumab-vfrm

  • Pharmaceutical Company

  • Teva

  • Helpline

  • Teva Shared Solutions® at 1-800-887-8100.

  • Injection Training Available

  • Yes, in-person injection training is available.

  • Dosing & Administration

  • Option 1: 225 mg monthly administered as one subcutaneous injection.

    Option 2: 675 mg (3x 225mg) every three months (quarterly), administered as three subcutaneous injections.

    Your doctor will determine which option is best for you.

  • Indication

  • Adults living with either chronic migraine (15 or more headache days per month) or episodic migraine (fewer than 15 headache days per month).

  • Sharps Container Available

  • No, but a guide on how to properly dispose of a used syringe is available on the Ajovy website.

  • Home Delivery Available

  • Yes, home delivery is an option through Teva Shared Solutions Pharmacy, which will coordinate the delivery of the refrigerated medication.

Join the CHAMP community